3 ms·
Biotech is a long and winding road. Going through the YC startup list from the beginning, a lot of the startups are either out of business (ubiome), some varia
by sjg007 7y ago
Biotech is a long and winding road. Going through the YC startup list from the beginning, a lot of the startups are either out of business (ubiome), some variant of snake oil, or an AI mashup for lead generation. Then there are a whole host liquid biopsy new entrants which is an extremely competitive space. The lab management software one seems the most promising actually since it is an established market.
https://blogs.sciencemag.org/pipeline/archives/2018/07/17/the-case-of-verge-genomics https://blogs.sciencemag.org/pipeline/archives/2018/07/17/th...
- wolco 7y agoUbiome patients sold for 7 million two weeks ago. Bad management but great idea.
- sjg007 7y agoSounds like they overpaid.
- DrAwdeOccarim 7y agoGinkgo is doing very well.
- sjg007 7y agohow so?